Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial

OBJECTIVE: Severe disease onset of COVID-19 may result in alveolar injury and respiratory failure. Apoptosis and inflammation are the main causes of respiratory distress syndrome. Berberine is used in medicine as an analgesic, anti-asthmatic, anti-inflammatory, and antiviral. In the current investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Omidvar Tehrani, Soodabeh, Ghasemzadeh Rahbardar, Mahboobeh, Shoorgashti, Kamran, Dehghan Nayeri, Mohammad Javad, Mohammadpour, Amir Hooshang, Hosseinzadeh, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465880/
https://www.ncbi.nlm.nih.gov/pubmed/37654997
http://dx.doi.org/10.22038/AJP.2022.21539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465880/
https://www.ncbi.nlm.nih.gov/pubmed/37654997
http://dx.doi.org/10.22038/AJP.2022.21539

Ejemplares similares